ACSL3 and cancer: We previously found that the acyl–coenzyme A (CoA) synthetase long-chain family member 3 (ACSL3) is necessary for the extracellular lipid utilization and proliferation of KRAS-driven cancer cells because of its role in activation of extracellularly derived long-chain fatty acids (10).